Ad is loading...
FLCSX
Price
$57.10
Change
+$0.27 (+0.48%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

FLCSX vs VVIAX

Header iconFLCSX vs VVIAX Comparison
Open Charts FLCSX vs VVIAXBanner chart's image
Fidelity Large Cap Stock
Price$57.10
Change+$0.27 (+0.48%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
FLCSX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FLCSX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCSX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. FLCSX (5.05B). VVIAX pays higher dividends than FLCSX: VVIAX (2.36) vs FLCSX (0.94). FLCSX was incepted earlier than VVIAX: FLCSX (29 years) vs VVIAX (24 years). VVIAX is a more actively managed with annual turnover of: 10.00 vs. FLCSX (8.00). FLCSX has a lower initial minimum investment than VVIAX: FLCSX (0) vs VVIAX (3000). FLCSX annual gain was more profitable for investors over the last year : 31.08 vs. VVIAX (26.09). FLCSX return over 5 years is better than : 79.97 vs. VVIAX (53.09).
FLCSXVVIAXFLCSX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years24 years-
Gain YTD26.35719.672134%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.05B184B3%
Annual Yield % from dividends0.942.3640%
Returns for 1 year31.0826.09119%
Returns for 3 years37.7624.77152%
Returns for 5 years79.9753.09151%
Returns for 10 years105.85112.2694%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics